MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
55.08
-1.63
-2.87%
After Hours: 55.24 +0.16 +0.29% 19:59 12/26 EST
OPEN
56.48
PREV CLOSE
56.71
HIGH
56.54
LOW
53.76
VOLUME
1.41M
TURNOVER
--
52 WEEK HIGH
78.48
52 WEEK LOW
30.04
MARKET CAP
5.25B
P/E (TTM)
-9.8710
1D
5D
1M
3M
1Y
5Y
1D
Cathie Wood Adds to WeRide (WRD) and CRISPR, Trims Ibotta (IBTA) in Holiday Trades, 12/24/25
TipRanks · 4d ago
Agios Pharma Stock: A Buy After FDA Approves Aqvesme
Seeking Alpha · 4d ago
Cathie Wood’s Christmas Trades: ARK Invest Bets on WeRide and CRISPR
TipRanks · 5d ago
CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know
NASDAQ · 5d ago
CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies
NASDAQ · 5d ago
Crispr Therapeutics Price Target Maintained With a $80.00/Share by Needham
Dow Jones · 5d ago
Early but Compelling CTX112 Data Underpin Buy Rating and $80 Target for CRISPR Therapeutics
TipRanks · 5d ago
Needham Reiterates Buy on CRISPR Therapeutics, Maintains $80 Price Target
Benzinga · 5d ago
More
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.